9 terminated. 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Terminated 9 |
Follow Hypertriglyceridemia: new trials by email Literature Review of Hypertriglyceridemia trials Research Report on Hypertriglyceridemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis evinacumab, Placebo - Hypertriglyceridemia | Phase 2 | Terminated | Regeneron Pharmaceuticals | 21 | 2021-07-12 | 2024-05-22 |
| Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes DS102, Placebo - Hypertriglyceridemia, Type 2 Diabetes | Phase 2 | Terminated | Afimmune | 233 | 2020-10-13 | 2023-06-12 |
| Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia SLx-4090 placebo, Orlistat Placebo, Orlistat - Type 1 Hyperlipoproteinemia | Phase 2 | Terminated | University of Texas Southwestern Medical Center | 5 | 2015-11-01 | 2021-08-19 |
| Supplementation With Omega-3: Mechanism of Action DHA-enriched, EPA-enriched - Hypertriglyceridemia | Phase 2 | Terminated | Johns Hopkins University | 13 | 2013-04-01 | 2017-03-01 |
| Efficacy of LCQ908 on Cardiovascular Risk pradigastat (LCQ908), Placebo - Coronary Artery Disease, Hypertriglyceridemia | Phase 2 | Terminated | Novartis Pharmaceuticals | 41 | 2011-12-01 | 2016-04-14 |
| Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children Omega Pure followed by placebo, Placebo followed by Omega Pure - Hypertriglyceridemia | Phase 2 | Terminated | The Hospital for Sick Children | 13 | 2008-06-01 | 2014-06-12 |
| Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides Lovaza, Placebo - Hypertriglyceridemia | Phase 2 | Terminated | Boston Children's Hospital | 25 | 2008-04-01 | 2013-05-29 |
| MK0859 Dose-Ranging Study (0859-003) MK0859 - Hypercholesterolemia, Mixed Hyperlipemia | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 500 | 2006-06-01 | 2015-03-02 |
| Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy implitapide - Hypertriglyceridemia | Phase 2 | Terminated | Medical Research Laboratories International | 50 | 2004-10-01 | 2005-06-24 |
Coronary Artery Disease (1) · Diabetes Mellitus, Type 2 (1) · Familial hyperchylomicronemia syndrome (1) · Hypercholesterolemia (1) · Hyperlipidemias (1) · Hyperlipoproteinemia Type V (1) · Pancreatitis (1)
Dyslipidemias (9) · Lipid Metabolism Disorders (9) · Metabolic Diseases (9) · Nutritional and Metabolic Diseases (9) · Hyperlipidemias (8) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1) · Glucose Metabolism Disorders (1)
6-(4'-trifluoromethyl-6-methoxybiphenyl-2-ylcarboxamido)-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid phenyl ester (1) · Corn Oil (1) · Omacor (1) · Orlistat (1) · anacetrapib (1) · epeleuton (1) · evinacumab (1) · implitapide (1) · pradigastat (1)
Afimmune (1) · Boston Children's Hospital (1) · Johns Hopkins University (1) · Medical Research Laboratories International (1) · Merck Sharp & Dohme LLC (1) · Novartis Pharmaceuticals (1) · Regeneron Pharmaceuticals (1) · The Hospital for Sick Children (1) · University of Texas Southwestern Medical Center (1)
United States (7) · Canada (2) · Germany (2) · Netherlands (2) · Georgia (1) · Israel (1) · Latvia (1) · Norway (1) · Switzerland (1)
Abhimanyu Garg, MD (1) · Ari Bitnun, MD, MSc (1) · Dhananjay Vaidya (1) · Jason Brophy, MD (1) · Markus Weissbach, MD (1) · Sara DeFerranti, MD (1) · Stanley Read, MD, PhD (1) · Stavroula K Osganian, MD, ScD (1)